Artículos por temáticas

Applying epigenetics to Alzheimer's disease via the latent early-life associated regulation (LEARn) model

Maloney B, Sambamurti K, Zawia N, Lahiri DK.

Curr Alzheimer Res. 2012 Jun;9(5):589-99. doi: 10.2174/156720512800617955.

Correlations between FDG PET glucose uptake-MRI gray matter volume scores and apolipoprotein E ε4 gene dose in cognitively normal adults: a cross-validation study using voxel-based multi-modal partial least squares

Chen K, Ayutyanont N, Langbaum JB, Fleisher AS, Reschke C, Lee W, Liu X, Alexander GE, Bandy D, Caselli RJ, Reiman EM.

Neuroimage. 2012 May 1;60(4):2316-22. doi: 10.1016/j.neuroimage.2012.02.005. Epub 2012 Feb 12.

[Implementation of section 87b of the guidelines of SGB XI--the point-of-view of the nurses aides]

Eberhardt D, Sadowski K.

Pflege Z. 2012 Feb;65(2):90-5.

Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET

Ossenkoppele R, Tolboom N, Foster-Dingley JC, Adriaanse SF, Boellaard R, Yaqub M, Windhorst AD, Barkhof F, Lammertsma AA, Scheltens P, van der Flier WM, van Berckel BN.

Eur J Nucl Med Mol Imaging. 2012 Jun;39(6):990-1000. doi: 10.1007/s00259-012-2102-3. Epub 2012 Mar 23.

Neural mechanisms of object naming and word comprehension in primary progressive aphasia

Hurley RS, Paller KA, Rogalski EJ, Mesulam MM.

J Neurosci. 2012 Apr 4;32(14):4848-55. doi: 10.1523/JNEUROSCI.5984-11.2012.

The clinical problem of symptomatic Alzheimer disease and mild cognitive impairment

Tarawneh R, Holtzman DM.

Cold Spring Harb Perspect Med. 2012 May;2(5):a006148. doi: 10.1101/cshperspect.a006148.

Creutzfeldt-Jakob disease revealed by a logopenic variant of primary progressive aphasia

Martory MD, Roth S, Lövblad KO, Neumann M, Lobrinus JA, Assal F.

Eur Neurol. 2012;67(6):360-2. doi: 10.1159/000336796. Epub 2012 May 17.

Interleukin-1α, interleukin-1β and tumor necrosis factor-α genetic variants and risk of dementia in the very old: evidence from the "Monzino 80-plus" prospective study

Albani D, Tettamanti M, Batelli S, Polito L, Dusi S, Ateri E, Forloni G, Lucca U.

Age (Dordr). 2012 Apr;34(2):519-26. doi: 10.1007/s11357-011-9249-x. Epub 2011 Apr 21.

Detection of activity limitations in older adults with MCI or Alzheimer's disease through evaluation of perceived difficulty in use of everyday technology: a replication study

Nygård L, Pantzar M, Uppgard B, Kottorp A.

Aging Ment Health. 2012;16(3):361-71. doi: 10.1080/13607863.2011.605055. Epub 2011 Sep 7.

Cell cycle proteins in brain in mild cognitive impairment: insights into progression to Alzheimer disease

Keeney JT, Swomley AM, Harris JL, Fiorini A, Mitov MI, Perluigi M, Sultana R, Butterfield DA.

Neurotox Res. 2012 Oct;22(3):220-30. doi: 10.1007/s12640-011-9287-2. Epub 2011 Nov 15.

Metabolic syndrome, cognitive performance, and dementia

Crichton GE, Elias MF, Buckley JD, Murphy KJ, Bryan J, Frisardi V.

J Alzheimers Dis. 2012;30 Suppl 2:S77-87. doi: 10.3233/JAD-2011-111022.

Frontotemporal lobar degeneration-related proteins induce only subtle memory-related deficits when bilaterally overexpressed in the dorsal hippocampus

Dayton RD, Wang DB, Cain CD, Schrott LM, Ramirez JJ, King MA, Klein RL.

Exp Neurol. 2012 Feb;233(2):807-14. doi: 10.1016/j.expneurol.2011.12.002. Epub 2011 Dec 9.

Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia

Buchhave P, Minthon L, Zetterberg H, Wallin AK, Blennow K, Hansson O.

Arch Gen Psychiatry. 2012 Jan;69(1):98-106. doi: 10.1001/archgenpsychiatry.2011.155.

Use of the CogState Brief Battery in the assessment of Alzheimer's disease related cognitive impairment in the Australian Imaging, Biomarkers and Lifestyle (AIBL) study

Lim YY, Ellis KA, Harrington K, Ames D, Martins RN, Masters CL, Rowe C, Savage G, Szoeke C, Darby D, Maruff P, The Aibl Research Group.

J Clin Exp Neuropsychol. 2012;34(4):345-58. doi: 10.1080/13803395.2011.643227. Epub 2012 Jan 17.

The role of S100a9 in the pathogenesis of Alzheimer's disease: the therapeutic effects of S100a9 knockdown or knockout

Chang KA, Kim HJ, Suh YH.

Neurodegener Dis. 2012;10(1-4):27-9. doi: 10.1159/000333781. Epub 2012 Feb 1.